Edwards Lifesciences Corporation Increase (Decrease) in Accounts and Other Receivables
Edwards Lifesciences Corporation (EW) reported Increase (Decrease) in Accounts and Other Receivables of $128.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2026-08-04
- Edwards Lifesciences Corporation increase (decrease) in accounts and other receivables for the quarter ending 2026-06-30 was $10.20M, a 59.04% decline year-over-year.
- Edwards Lifesciences Corporation increase (decrease) in accounts and other receivables for the quarter ending 2026-03-31 was $117.90M, a 169.79% increase year-over-year.
- Edwards Lifesciences Corporation increase (decrease) in accounts and other receivables for the quarter ending 2025-12-31 was -$32.40M.
- Edwards Lifesciences Corporation increase (decrease) in accounts and other receivables for the quarter ending 2025-09-30 was -$13.20M.
- Edwards Lifesciences Corporation increase (decrease) in accounts and other receivables for fiscal 2025 was $23.00M.
- Edwards Lifesciences Corporation increase (decrease) in accounts and other receivables for fiscal 2024 was -$121.20M, a 185.84% decline from fiscal 2023.
- Edwards Lifesciences Corporation increase (decrease) in accounts and other receivables for fiscal 2023 was $141.20M, a 67.90% increase from fiscal 2022.
- Edwards Lifesciences Corporation increase (decrease) in accounts and other receivables for fiscal 2022 was $84.10M, a 7.68% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts and Other Receivables 3 month | Increase (Decrease) in Accounts and Other Receivables 3 month as first filed | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 6 month as first filed | Increase (Decrease) in Accounts and Other Receivables 9 month | Increase (Decrease) in Accounts and Other Receivables 9 month as first filed | Increase (Decrease) in Accounts and Other Receivables 12 month | Increase (Decrease) in Accounts and Other Receivables 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $128.10M 10-Q · filed 2026-08-04 | $95.70M derived: sum of 3 quarters · filed 2026-08-04 | $82.50M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $117.90M 10-Q · filed 2026-05-06 | $85.50M derived: sum of 2 quarters · filed 2026-05-06 | $72.30M derived: sum of 3 quarters · filed 2026-05-06 | $97.20M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$32.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$45.60M derived: sum of 2 quarters · filed 2026-02-25 | -$20.70M derived: sum of 3 quarters · filed 2026-08-04 | $23.00M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | -$13.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $11.70M derived: sum of 2 quarters · filed 2026-08-04 | $55.40M 10-Q · filed 2025-11-05 | -$50.50M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $24.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $68.60M 10-Q · filed 2026-08-04 | -$37.30M derived: sum of 3 quarters · filed 2026-08-04 | -$84.60M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $43.70M 10-Q · filed 2026-05-06 | -$62.20M derived: sum of 2 quarters · filed 2026-05-06 | -$109.50M derived: sum of 3 quarters · filed 2026-05-06 | -$132.50M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$105.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$153.20M derived: sum of 2 quarters · filed 2026-02-25 | -$176.20M derived: sum of 3 quarters · filed 2026-02-25 | -$121.20M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | -$47.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$70.30M derived: sum of 2 quarters · filed 2025-11-05 | -$15.30M 10-Q · filed 2025-11-05 | $2.90M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | -$23.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $32.00M 10-Q · filed 2025-08-06 | $50.20M derived: sum of 3 quarters · filed 2026-02-25 | $48.90M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $55.00M 10-Q · filed 2025-05-06 | $73.20M derived: sum of 2 quarters · filed 2026-02-25 | $71.90M derived: sum of 3 quarters · filed 2026-02-25 | $118.70M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $18.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $16.90M derived: sum of 2 quarters · filed 2026-02-25 | $63.70M derived: sum of 3 quarters · filed 2026-02-25 | $141.20M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $45.50M derived: sum of 2 quarters · filed 2024-11-06 | $123.00M 10-Q · filed 2024-11-06 | $124.10M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $46.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $124.30M 10-Q · filed 2024-07-31 | $125.40M derived: sum of 3 quarters · filed 2025-02-28 | $130.70M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $77.50M 10-Q · filed 2024-04-29 | $78.60M derived: sum of 2 quarters · filed 2025-02-28 | $83.90M derived: sum of 3 quarters · filed 2025-02-28 | $103.80M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $6.40M derived: sum of 2 quarters · filed 2025-02-28 | $26.30M derived: sum of 3 quarters · filed 2025-02-28 | $84.10M 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $5.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $25.20M derived: sum of 2 quarters · filed 2023-10-27 | $83.00M 10-Q · filed 2023-10-27 | $76.20M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-06-30 | $19.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $77.70M 10-Q · filed 2023-07-28 | $70.90M derived: sum of 3 quarters · filed 2024-02-12 | $32.90M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-03-31 | $57.80M 10-Q · filed 2023-04-28 | $51.00M derived: sum of 2 quarters · filed 2024-02-12 | $13.00M derived: sum of 3 quarters · filed 2024-02-12 | $59.40M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2021-12-31 | -$6.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | -$44.80M derived: sum of 2 quarters · filed 2024-02-12 | $1.60M derived: sum of 3 quarters · filed 2024-02-12 | $91.10M 10-K · filed 2024-02-12 | ||||
| 2021-09-30 | -$38.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $8.40M derived: sum of 2 quarters · filed 2022-10-28 | $97.90M 10-Q · filed 2022-10-28 | $46.80M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-06-30 | $46.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $135.90M 10-Q · filed 2022-07-29 | $84.80M derived: sum of 3 quarters · filed 2023-02-13 | $115.50M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-03-31 | $89.50M 10-Q · filed 2022-04-28 | $38.40M derived: sum of 2 quarters · filed 2023-02-13 | $69.10M derived: sum of 3 quarters · filed 2023-02-13 | $43.40M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2020-12-31 | -$51.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | -$20.40M derived: sum of 2 quarters · filed 2023-02-13 | -$46.10M derived: sum of 3 quarters · filed 2023-02-13 | -$41.90M 10-K · filed 2023-02-13 | ||||
| 2020-09-30 | $30.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $5.00M derived: sum of 2 quarters · filed 2021-10-29 | $9.20M 10-Q · filed 2021-10-29 | $26.90M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-06-30 | -$25.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$21.50M 10-Q · filed 2021-07-30 | -$3.80M derived: sum of 3 quarters · filed 2022-02-14 | -$22.70M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-03-31 | $4.20M 10-Q · filed 2021-04-28 | $21.90M derived: sum of 2 quarters · filed 2022-02-14 | $3.00M derived: sum of 3 quarters · filed 2022-02-14 | $46.40M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2019-12-31 | $17.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | -$1.20M derived: sum of 2 quarters · filed 2022-02-14 | $42.20M derived: sum of 3 quarters · filed 2022-02-14 | $88.00M 10-K · filed 2022-02-14 | ||||
| 2019-09-30 | -$18.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | $24.50M derived: sum of 2 quarters · filed 2020-10-26 | $70.30M 10-Q · filed 2020-10-26 | $98.70M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-06-30 | $43.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | $89.20M 10-Q · filed 2020-07-27 | $117.60M derived: sum of 3 quarters · filed 2021-02-12 | $120.50M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-03-31 | $45.80M 10-Q · filed 2020-04-28 | $74.20M derived: sum of 2 quarters · filed 2021-02-12 | $77.10M derived: sum of 3 quarters · filed 2021-02-12 | $101.90M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2018-12-31 | $28.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $31.30M derived: sum of 2 quarters · filed 2021-02-12 | $56.10M derived: sum of 3 quarters · filed 2021-02-12 | $28.70M 10-K · filed 2021-02-12 | ||||
| 2018-09-30 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $27.70M derived: sum of 2 quarters · filed 2019-10-25 | $300.00K 10-Q · filed 2019-10-25 | $7.40M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-06-30 | $24.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | -$2.60M 10-Q · filed 2019-07-26 | $4.50M derived: sum of 3 quarters · filed 2020-02-14 | -$49.60M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-03-31 | -$27.40M 10-Q · filed 2019-04-26 | -$29.90M 10-Q · filed 2018-04-27 | -$20.30M derived: sum of 2 quarters · filed 2020-02-14 | -$74.40M derived: sum of 3 quarters · filed 2020-02-14 | -$81.10M derived: sum of 4 quarters · filed 2020-02-14 | |||
| 2017-12-31 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | -$47.00M derived: sum of 2 quarters · filed 2020-02-14 | -$53.70M derived: sum of 3 quarters · filed 2020-02-14 | $27.80M 10-K · filed 2020-02-14 | $3.90M 10-K · filed 2018-02-16 | |||
| 2017-09-30 | -$54.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | -$60.80M derived: sum of 2 quarters · filed 2018-10-26 | $20.70M 10-Q · filed 2018-10-26 | $14.40M 10-Q · filed 2017-10-27 | $26.30M derived: sum of 4 quarters · filed 2019-02-15 | |||
| 2017-06-30 | -$6.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $74.80M 10-Q · filed 2018-07-27 | $70.50M 10-Q · filed 2017-07-28 | $80.40M derived: sum of 3 quarters · filed 2019-02-15 | $70.50M derived: sum of 4 quarters · filed 2019-02-15 | |||
| 2017-03-31 | $81.50M 10-Q · filed 2018-04-27 | $87.10M derived: sum of 2 quarters · filed 2019-02-15 | $77.20M derived: sum of 3 quarters · filed 2019-02-15 | $109.70M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2016-12-31 | $5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | -$4.30M derived: sum of 2 quarters · filed 2019-02-15 | $28.20M derived: sum of 3 quarters · filed 2019-02-15 | $60.40M 10-K · filed 2019-02-15 | $56.70M 10-K · filed 2017-02-17 | |||
| 2016-09-30 | -$9.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $22.60M derived: sum of 2 quarters · filed 2017-10-27 | $54.80M 10-Q · filed 2017-10-27 | $64.80M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-06-30 | $32.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $64.70M 10-Q · filed 2017-07-28 | $74.70M derived: sum of 3 quarters · filed 2018-02-16 | $63.50M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-03-31 | $32.20M 10-Q · filed 2017-04-28 | $42.20M derived: sum of 2 quarters · filed 2018-02-16 | $31.00M derived: sum of 3 quarters · filed 2018-02-16 | $34.00M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2015-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$1.20M derived: sum of 2 quarters · filed 2018-02-16 | $1.80M derived: sum of 3 quarters · filed 2018-02-16 | $38.30M 10-K · filed 2018-02-16 | ||||
| 2015-09-30 | -$11.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | -$8.20M derived: sum of 2 quarters · filed 2016-10-28 | $28.30M 10-Q · filed 2016-10-28 | $44.40M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $39.50M 10-Q · filed 2016-07-29 | $55.60M derived: sum of 3 quarters · filed 2017-02-17 | $66.10M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-03-31 | $36.50M 10-Q · filed 2016-04-29 | $52.60M derived: sum of 2 quarters · filed 2017-02-17 | $63.10M derived: sum of 3 quarters · filed 2017-02-17 | $86.00M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2014-12-31 | $16.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $26.60M derived: sum of 2 quarters · filed 2017-02-17 | $49.50M derived: sum of 3 quarters · filed 2017-02-17 | $26.80M 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | $10.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $33.40M derived: sum of 2 quarters · filed 2015-10-29 | $10.70M 10-Q · filed 2015-10-29 | $11.40M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $22.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $200.00K 10-Q · filed 2015-07-29 | $900.00K derived: sum of 3 quarters · filed 2016-02-19 | -$17.00M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | -$22.70M 10-Q · filed 2015-04-29 | -$22.00M derived: sum of 2 quarters · filed 2016-02-19 | -$39.90M derived: sum of 3 quarters · filed 2016-02-19 | -$25.80M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$17.20M derived: sum of 2 quarters · filed 2016-02-19 | -$3.10M derived: sum of 3 quarters · filed 2016-02-19 | -$8.50M 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | -$17.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | -$3.80M derived: sum of 2 quarters · filed 2014-10-31 | -$9.20M 10-Q · filed 2014-10-31 | $13.30M derived: sum of 4 quarters · filed 2015-02-20 | ||||
| 2013-06-30 | $14.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $8.70M 10-Q · filed 2014-08-04 | $31.20M derived: sum of 3 quarters · filed 2015-02-20 | $13.00M derived: sum of 4 quarters · filed 2015-02-20 | ||||
| 2013-03-31 | -$5.40M 10-Q · filed 2014-05-02 | $17.10M derived: sum of 2 quarters · filed 2015-02-20 | -$1.10M derived: sum of 3 quarters · filed 2015-02-20 | -$3.80M derived: sum of 4 quarters · filed 2015-02-20 | ||||
| 2012-12-31 | $22.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | $4.30M derived: sum of 2 quarters · filed 2015-02-20 | $1.60M derived: sum of 3 quarters · filed 2015-02-20 | $26.50M 10-K · filed 2015-02-20 | ||||
| 2012-09-30 | -$18.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$20.90M derived: sum of 2 quarters · filed 2013-11-07 | $4.00M 10-Q · filed 2013-11-07 | $19.20M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | -$2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $22.20M 10-Q · filed 2013-08-06 | $37.40M derived: sum of 3 quarters · filed 2014-02-28 | $27.60M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $24.90M 10-Q · filed 2013-05-06 | $40.10M derived: sum of 2 quarters · filed 2014-02-28 | $30.30M derived: sum of 3 quarters · filed 2014-02-28 | $43.70M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $15.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $5.40M derived: sum of 2 quarters · filed 2014-02-28 | $18.80M derived: sum of 3 quarters · filed 2014-02-28 | $53.70M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | -$9.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $3.60M derived: sum of 2 quarters · filed 2012-11-07 | $38.50M 10-Q · filed 2012-11-07 | $40.90M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $13.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $48.30M 10-Q · filed 2012-08-07 | $50.70M derived: sum of 3 quarters · filed 2013-02-28 | $41.40M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $34.90M 10-Q · filed 2012-05-09 | $37.30M derived: sum of 2 quarters · filed 2013-02-28 | $28.00M derived: sum of 3 quarters · filed 2013-02-28 | $53.50M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$6.90M derived: sum of 2 quarters · filed 2013-02-28 | $18.60M derived: sum of 3 quarters · filed 2013-02-28 | $34.20M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | -$9.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $16.20M derived: sum of 2 quarters · filed 2011-11-08 | $31.80M 10-Q · filed 2011-11-08 | $38.60M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-06-30 | $25.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $41.10M 10-Q · filed 2011-08-08 | $47.90M derived: sum of 3 quarters · filed 2012-02-27 | $37.90M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-03-31 | $15.60M 10-Q · filed 2011-05-09 | $22.40M derived: sum of 2 quarters · filed 2012-02-27 | $12.40M derived: sum of 3 quarters · filed 2012-02-27 | |||||
| 2009-12-31 | $6.80M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | -$3.20M derived: sum of 2 quarters · filed 2012-02-27 | $58.90M 10-K · filed 2012-02-27 | |||||
| 2009-09-30 | -$10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $52.10M 10-Q · filed 2010-11-08 | ||||||
| 2009-06-30 | $62.10M 10-Q · filed 2010-08-06 | |||||||
| 2008-12-31 | $61.10M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |